Delcath Systems (DCTH) vs Tactile Systems Technology (TCMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tactile Systems Technology (TCMD) has outperformed Delcath Systems (DCTH) over the past year, gaining 48.5% versus a gain of 35.5%. Over five years, DCTH leads with a +59.8% price change compared with -37.7% for TCMD. Delcath Systems is the larger company by market cap ($530.7 million vs $506.3 million), about 1.0 times the size.
On valuation, Tactile Systems Technology trades at a lower forward P/E (15.4x vs 339.9x for Delcath Systems).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCTH | TCMD |
|---|---|---|
| Share price | $15.30 | $22.35 |
| Market cap | $530.72M | $506.28M |
| 1-day change | +1.70% | +1.04% |
| YTD return | +48.91% | -23.72% |
| 1-year return | +35.50% | +48.46% |
| 5-year return | +59.83% | -37.69% |
| P/E ratio (TTM) | — | 20.69 |
| Forward P/E | 339.89 | 15.36 |
| EPS (TTM) | $0.01 | $1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.42 | $37.77 |
| 52-week low | $8.12 | $14.00 |
| Distance from 52-week high | -12.20% | -40.83% |
| Analyst consensus | none | none |
| Avg. price target upside | +56.91% | +74.50% |
| Average volume | 479.73K | 298.31K |
| Shares outstanding | 34.70M | 22.65M |
| Employees | 156 | 1,086 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TCMD has outperformed DCTH by 13.0 percentage points over the past year.
About Delcath Systems
DCTH stock →Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Health Care · Medical/Dental Instruments · 156 employees
About Tactile Systems Technology
TCMD stock →Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Health Care · Medical/Dental Instruments · 1,086 employees
DCTH vs TCMD FAQ
Which is bigger, Delcath Systems or Tactile Systems Technology?
Delcath Systems (DCTH) is larger, with a market capitalization of $530.72M compared with $506.28M for Tactile Systems Technology (TCMD).
Which stock has performed better over the past year, DCTH or TCMD?
TCMD returned +48.46% over the past 12 months, compared with +35.50% for DCTH (price return, excluding dividends). Past performance does not predict future results.
Are Delcath Systems and Tactile Systems Technology in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.